Background And Aims: Meteorin-like protein (Metrnl) has been recently suggested as a new adipokine with protective cardiovascular effects. Its circulating levels in patients seem to be associated with heart failure (HF), although with contradictory results. Our aim was to ascertain whether this adipokine could estimate the prognosis of HF in de novo HF (DNHF) patients.
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
December 2024
Introduction And Objectives: We report the results of the 2023 Spanish catheter ablation registry.
Methods: Procedural data were collected and incorporated into the REDCap platform by all participating centers through a specific form.
Results: There were 104 participating centers in 2023 compared with 103 in 2022.
Recurrence of atrial fibrillation (AF) despite successful isolation of the pulmonary veins (PVs) represents a great challenge. We present a patient with recurrent episodes of paroxysmal AF despite PV isolation in which a non-PV trigger was identified in the inferior vena cava. ().
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
July 2022
We describe through a clinical case some of the challenges we can face when remotely monitoring a patient with two devices. The case describes a patient with two leadless pacemaker in which data transmission by remote monitoring has been achieved.
View Article and Find Full Text PDFBackground: A male predominance in Brugada syndrome (BrS) has been widely reported, but scarce information on female patients with BrS is available.
Objective: The purpose of this study was to investigate the clinical characteristics and long-term prognosis of women with BrS.
Methods: A multicenter retrospective study of patients diagnosed with BrS and previous electrophysiological study (EPS) was performed.
Introduction And Objectives: The Micra transcatheter pacing system has shown high effectiveness and a lower complication rate than conventional transvenous pacemakers. However, the benefit of the device is unknown in the very old population (≥ 90 years). The aim of this study was to evaluate the safety and effectiveness of Micra in patients ≥ 90 years.
View Article and Find Full Text PDFThis article contains a review of some of the most significant advances in cardiac arrhythmias that have taken place in the last year, particularly those concerning the most common clinical conditions associated with the risk of arrhythmia, such as sudden cardiac death, atrial fibrillation and syncope, and genetically determined and hereditary heart disease, as well as advances concerning the principal nonpharmacologic treatments, such as catheter ablation, and the use of implantable defibrillators and cardiac resynchronization therapy.
View Article and Find Full Text PDFA 59-year-old man with Wolff-Parkinson-White syndrome and an infrahepatic interruption of his inferior vena cava with an azygos continuation underwent a successful ablation of a right anteroseptal accessory pathway with a femoral approach through the azygos vein and superior vena cava.
View Article and Find Full Text PDF